Given that serum soluble LAMP1 was elevated in patients with proliferative LN and considering that LN is characterized by increased myeloid cell activation in the kidney, we hypothesized that LAMP1 might also be released into the urine. The gene discussed is LAMP1; the disease is lobular neoplasia.